Ovoca Bio plc
LSE OVB.L
Ovoca Bio plc Market Capitalization on January 14, 2025: USD 1.68 M
-
Ovoca Bio plc 52-week high Market Capitalization is USD 2.03 M on October 21, 2024, which is 21.00% above the current Market Capitalization.
-
Ovoca Bio plc 52-week low Market Capitalization is USD 494.14 K on April 10, 2024, which is -70.59% below the current Market Capitalization.
-
Ovoca Bio plc average Market Capitalization for the last 52 weeks is USD 1.02 M.
| Date | Market Capitalization | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) |
|---|
| CEO | Mr. Timothy Rand McCutcheon |
| IPO Date | Jan. 4, 2000 |
| Location | Ireland |
| Headquarters | 17 Pembroke Street Upper |
| Employees | 5 |
| Sector | Health Care |
| Industries | |
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder, which is in phase II clinical study in Australia and New Zealand, and in phase III clinical trials in Russia. It also engages in mineral exploration, as well as provides support services. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.
Past 5 years
USD 4.80
USD 0.04
USD 0.01
StockViz Staff
January 15, 2025
Any question? Send us an email